---
title: "PHARMARON: The group is collaborating with multiple companies in different fields to advance its business development goals"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/278884053.md"
description: "PHARMARON announced that it has confirmed a production cooperation with the Chinese subsidiary of a leading international pharmaceutical company, which is part of its routine business. The company stated that it will collaborate with multiple companies to promote business development and has not identified any information that needs to be disclosed to avoid creating a false market, nor is there a need to disclose insider information"
datetime: "2026-03-12T12:32:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278884053.md)
  - [en](https://longbridge.com/en/news/278884053.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278884053.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/278884053.md) | [繁體中文](https://longbridge.com/zh-HK/news/278884053.md)


# PHARMARON: The group is collaborating with multiple companies in different fields to advance its business development goals

According to the announcement from Kanglong Huacheng (03759), the company confirmed after reasonable inquiries regarding recent news reports about the group's production cooperation with a Chinese subsidiary of a leading international pharmaceutical company that the aforementioned production cooperation was established and will be conducted in the course of the group's daily and general business operations. In its daily operations, the group collaborates with various companies in different fields to advance its business development goals. Furthermore, the company is not aware of any information that needs to be disclosed to avoid creating a false market for the company's securities, nor is it aware of any insider information that must be disclosed under Listing Rule 13.09(2) and Part XIVA of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong)

### 相关股票

- [PHARMARON (03759.HK)](https://longbridge.com/zh-CN/quote/03759.HK.md)

## 相关资讯与研究

- [Pharmaron Beijing Sets Out Board and Committee Structure for Third Board Session](https://longbridge.com/zh-CN/news/270177231.md)
- [Global Penny Stocks To Watch In April 2026](https://longbridge.com/zh-CN/news/281341259.md)
- [Sincere FY loss attributable HK$64.1 million](https://longbridge.com/zh-CN/news/281220904.md)
- [CATL's controlling shareholder to donate some A-shares](https://longbridge.com/zh-CN/news/281197776.md)
- [China Longyuan Power's Profit, Revenue Decline in 2025](https://longbridge.com/zh-CN/news/281300557.md)